BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Expression data from breast cancer FNA biopsies from patients (US samples)

Dataset: Expression data from breast cancer FNA biopsies from patients (US samples)

This is Phase II Trial of 4courses of 5-fluorouracil, doxorubicin and cyclophosphamide follwed by 4 additional courses of weekly...

Registered by ArrayExpress Uploader
View Dataset

This is Phase II Trial of 4courses of 5-fluorouracil, doxorubicin and cyclophosphamide follwed by 4 additional courses of weekly docetaxel and capecitabine administered as Preoperative Therapy for Patients with Locally Advanced Breast Cancer, Stages II and III by US oncology (PROTOCOL 02-103) We performed gene set analysis (GSA) using functionally annotated gene sets corresponding to almost all known biological processes in ER-positive/HER2negative and ER-negative/HER2-negative breast cancer, respectively. Pre-treatment FNA from primary tumors were obtained and RNA extracted and hybridized to afymetrix microarrays according to manufacturer protocol.

Species:
human

Samples:
61

Source:
E-GEOD-23988

PubMed:
21191116

Updated:
Dec.12, 2014

Registered:
Jun.19, 2014


Factors: (via ArrayExpress)
Sample PCR.V.RD ER POSITIVE VS NEGATIVE GRADE AGE PRECHEMO TUMOR SIZE PRECHEMO NODAL STATUS PRECHEMO T STAGE
GSM590900 RD ERpos 3 44.225 4 1 2
GSM590899 RD ERpos 2 58.130 6 2 3
GSM590898 RD ERneg 3 61.073 3.4 0 2
GSM590897 RD ERpos 2 57.654 3 1 2
GSM590896 pCR ERneg NA 52.808 4 0 2
GSM590895 RD ERpos 2 46.004 3.5 1 2
GSM590894 pCR ERneg 3 45.963 6 3 3
GSM590893 RD ERpos 3 45.232 6 0 3
GSM590892 RD ERpos 3 54.549 5 0 2
GSM59089 RD ERpos 2 42.565 5.5 1 3
GSM590890 pCR ERneg 3 48.433 8 0 3
GSM590889 pCR ERneg 3 46.782 4 1 2
GSM590888 RD ERpos 2 34.075 6 0 3
GSM590887 RD ERpos 2 47.899 10 1 3
GSM590886 RD ERneg 3 32.578 2 1 1
GSM590885 pCR ERneg NA 49.607 6.5 0 3
GSM590884 RD ERneg 2 38.593 13 0 3
GSM590883 RD ERpos 2 52.485 7 0 3
GSM590882 pCR ERpos 3 40.337 2.3 2 2
GSM59088 pCR ERpos 3 47.392 7 0 3
GSM590880 RD ERneg 3 55.658 6 1 3
GSM590879 RD ERneg 3 66.710 5.5 1 3
GSM590878 pCR ERpos 2 50.056 4 1 2
GSM590877 RD ERneg 3 33.539 11.8 2 3
GSM590876 RD ERpos 3 44.402 6 1 3
GSM590875 pCR ERpos 3 52.745 10 1 3
GSM590874 pCR ERneg 3 40.687 3.5 3 2
GSM590873 RD ERneg 3 62.341 2.5 1 2
GSM590872 RD ERpos 2 59.472 10 1 3
GSM59087 RD ERneg 3 43.893 5.5 2 3
GSM590870 pCR ERneg 2 49.246 7.5 0 3
GSM590869 pCR ERneg 3 50.300 3.5 1 2
GSM590868 RD ERpos NA 26.086 14 1 3
GSM590867 RD ERneg 3 66.820 11.5 1 3
GSM590866 RD ERpos 3 45.109 11 1 3
GSM590865 RD ERpos 2 55.934 8 1 3
GSM590864 RD ERneg 2 60.860 4 1 2
GSM590863 RD ERpos 3 41.273 5.3 1 3
GSM590862 RD ERneg 3 65.314 17.5 2 3
GSM59086 RD ERpos 3 60.099 6 0 3
GSM590860 pCR ERneg 3 51.132 6 1 3
GSM590859 RD ERpos 1 45.363 4 0 2
GSM590858 RD ERneg 3 59.231 15 0 3
GSM590857 RD ERpos 2 51.461 6.5 0 3
GSM590856 RD ERpos 3 46.943 6 1 3
GSM590855 pCR ERneg 3 50.064 7.5 1 3
GSM590854 RD ERpos 3 53.988 6 0 3
GSM590853 RD ERneg 2 65.054 11 1 3
GSM590852 RD ERneg 3 49.010 6 0 3
GSM59085 RD ERneg 3 40.337 5 1 2
GSM590850 pCR ERneg 3 43.028 8 1 3
GSM590849 RD ERpos 3 57.536 5 1 2
GSM590848 pCR ERneg 3 34.059 7 0 3
GSM590847 RD ERpos 2 47.118 7 1 3
GSM590846 pCR ERpos 3 50.771 10 1 3
GSM590845 pCR ERpos 3 43.775 8 3 3
GSM590844 pCR ERpos 2 47.099 3.5 0 2
GSM590843 RD ERpos 2 36.739 4 1 2
GSM590842 pCR ERneg 3 41.914 3 1 2
GSM59084 RD ERpos 2 32.197 4.5 0 2
GSM590840 RD ERneg NA 46.209 6 0 3

Tags

  • breast
  • breast cancer
  • cancer

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2025 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use